EditorialLouis Shantzek, a retiree who tried unsuccessfully to get a monoclonal antibody treatment after he tested positive for COVID, at home in Miami, Jan. 3, 2022. (Scott McIntyre/The New York Times)
EditorialDr. Howard Huang, Houston Methodist’s medical leader for the antibody infusion program, in Texas on Wednesday, Sept. 15, 2021. (Brandon Thibodeaux/The New York Times)